Sartorius Aktiengesellschaft (SARTF) Q2 2025 Earnings Call Transcript

2025-07-22 10:24:06 ET

Sartorius Aktiengesellschaft (SARTF)

Q2 2025 Earnings Conference Call

July 22, 2025, 07:00 AM ET

Company Participants

Alexandra Gatzemeyer - Head of the Lab Products & Services Division and Member of Executive Board

Florian Funck - CFO & Member of Executive Board

Michael Grosse - CEO & Chairman of the Executive Board

Rene Faber - Head of Bioprocess Solutions Division & Member of Executive Board

Conference Call Participants

Charles Pitman - Barclays Bank PLC, Research Division

Charles Robert Weston - RBC Capital Markets, Research Division

Charlie Haywood - BofA Securities, Research Division

Delphine Le Louet - Sanford C. Bernstein & Co., LLC., Research Division

Douglas Anthony Schenkel - Wolfe Research, LLC

Dylan van Haaften - Stifel, Nicolaus & Company, Incorporated, Research Division

Harry Thomas d'Alton Sephton - UBS Investment Bank, Research Division

James Alexander Stewart Vane- Tempest - Jefferies LLC, Research Division

James Patrick Quigley - Goldman Sachs Group, Inc., Research Division

Odysseas Manesiotis - BNP Paribas Exane, Research Division

Oliver Metzger - ODDO BHF Corporate & Markets, Research Division

Richard Vosser - JPMorgan Chase & Co, Research Division

Subhalaxmi T. Nambi - Guggenheim Securities, LLC, Research Division

Thibault Boutherin - Morgan Stanley, Research Division

Thomas DeBourcy - Nephron Research LLC

Presentation

Operator

Ladies and gentlemen, welcome to the Sartorius and Sartorius Stedim Biotech H1 2025 Conference Call and Live Webcast. I am Mathilde, the Chorus Call operator. [Operator Instructions] The conference is being recorded. This call is scheduled for 60 minutes. Presentation will be followed by a Q&A session. [Operator Instructions] The conference must not be recorded for publication or broadcast....

Read the full article on Seeking Alpha

For further details see: